DE602006008278D1 - Pharmazeutische zusammensetzung - Google Patents
Pharmazeutische zusammensetzungInfo
- Publication number
- DE602006008278D1 DE602006008278D1 DE602006008278T DE602006008278T DE602006008278D1 DE 602006008278 D1 DE602006008278 D1 DE 602006008278D1 DE 602006008278 T DE602006008278 T DE 602006008278T DE 602006008278 T DE602006008278 T DE 602006008278T DE 602006008278 D1 DE602006008278 D1 DE 602006008278D1
- Authority
- DE
- Germany
- Prior art keywords
- composition
- microparticle
- pharmaceutical composition
- production
- ifn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000011859 microparticle Substances 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 102000006992 Interferon-alpha Human genes 0.000 abstract 1
- 108010047761 Interferon-alpha Proteins 0.000 abstract 1
- 229920002988 biodegradable polymer Polymers 0.000 abstract 1
- 239000004621 biodegradable polymer Substances 0.000 abstract 1
- 210000004443 dendritic cell Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 229920002521 macromolecule Polymers 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 abstract 1
- 229920002477 rna polymer Polymers 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/07—Bacillus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0504276A GB0504276D0 (en) | 2005-03-02 | 2005-03-02 | Pharmaceutical composition |
| GB0511801A GB0511801D0 (en) | 2005-06-10 | 2005-06-10 | Pharmaceutical composition |
| PCT/GB2006/000751 WO2006092607A1 (en) | 2005-03-02 | 2006-03-02 | Pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602006008278D1 true DE602006008278D1 (de) | 2009-09-17 |
Family
ID=36353665
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602006008278T Active DE602006008278D1 (de) | 2005-03-02 | 2006-03-02 | Pharmazeutische zusammensetzung |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20080138431A1 (de) |
| EP (1) | EP1853227B1 (de) |
| JP (1) | JP2008531672A (de) |
| AT (1) | ATE438385T1 (de) |
| AU (1) | AU2006219717B2 (de) |
| CA (1) | CA2599329A1 (de) |
| DE (1) | DE602006008278D1 (de) |
| WO (1) | WO2006092607A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ573064A (en) | 2002-04-04 | 2011-02-25 | Coley Pharm Gmbh | Immunostimulatory G,U-containing oligoribonucleotides |
| BRPI0622298A8 (pt) | 2005-11-25 | 2016-04-05 | Coley Pharm Gmbh | Oligorribonucleotídeo para estimular a produção de uma citocina pró-inflamatória, uso do mesmo e composição contendo tal oligorribonucleotídeo |
| AU2009241645B2 (en) * | 2008-05-02 | 2014-07-17 | Blink Therapeutics Limited | Products and methods for stimulating an immune response |
| BR112013000392B8 (pt) | 2010-07-06 | 2022-10-04 | Novartis Ag | Composição farmacêutica contendo partícula de distribuição semelhante a vírion para moléculas de rna autorreplicantes e seu uso |
| WO2012006378A1 (en) | 2010-07-06 | 2012-01-12 | Novartis Ag | Liposomes with lipids having an advantageous pka- value for rna delivery |
| US9770463B2 (en) | 2010-07-06 | 2017-09-26 | Glaxosmithkline Biologicals Sa | Delivery of RNA to different cell types |
| HUE047796T2 (hu) | 2010-07-06 | 2020-05-28 | Glaxosmithkline Biologicals Sa | RNS bevitele több immunútvonal bekapcsolására |
| PT2591114T (pt) | 2010-07-06 | 2016-08-02 | Glaxosmithkline Biologicals Sa | Imunização de mamíferos de grande porte com doses baixas de arn |
| LT4066855T (lt) | 2010-08-31 | 2023-03-10 | Glaxosmithkline Biologicals Sa | Pegilintos liposomos, skirtos imunogeną koduojančios rnr tiekimui |
| ES2716243T3 (es) | 2010-10-11 | 2019-06-11 | Glaxosmithkline Biologicals Sa | Plataformas de suministro de antígenos |
| ES2656050T3 (es) | 2011-07-06 | 2018-02-22 | Glaxosmithkline Biologicals Sa | Composiciones de combinación inmunogénica y usos de las mismas |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR012448A1 (es) * | 1997-04-18 | 2000-10-18 | Ipsen Pharma Biotech | Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada |
| CA2462646C (en) * | 2001-10-03 | 2013-02-12 | Chiron Corporation | Adjuvanted meningococcus compositions |
| BRPI0406628A (pt) * | 2003-01-06 | 2005-12-06 | Corixa Corp | Determinados compostos de fosfato de aminoalquil glucosaminida e seu uso |
| AU2004225480A1 (en) * | 2003-03-26 | 2004-10-14 | Multicell Immunotherapeutics, Inc. | Selected RNA motifs to include cell death and/or apoptosis |
-
2006
- 2006-03-02 AU AU2006219717A patent/AU2006219717B2/en not_active Ceased
- 2006-03-02 US US11/885,538 patent/US20080138431A1/en not_active Abandoned
- 2006-03-02 DE DE602006008278T patent/DE602006008278D1/de active Active
- 2006-03-02 WO PCT/GB2006/000751 patent/WO2006092607A1/en not_active Application Discontinuation
- 2006-03-02 EP EP06709975A patent/EP1853227B1/de not_active Not-in-force
- 2006-03-02 JP JP2007557589A patent/JP2008531672A/ja active Pending
- 2006-03-02 CA CA002599329A patent/CA2599329A1/en not_active Abandoned
- 2006-03-02 AT AT06709975T patent/ATE438385T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006219717B2 (en) | 2009-05-21 |
| JP2008531672A (ja) | 2008-08-14 |
| CA2599329A1 (en) | 2006-09-08 |
| EP1853227B1 (de) | 2009-08-05 |
| ATE438385T1 (de) | 2009-08-15 |
| AU2006219717A1 (en) | 2006-09-08 |
| WO2006092607A1 (en) | 2006-09-08 |
| US20080138431A1 (en) | 2008-06-12 |
| EP1853227A1 (de) | 2007-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE438385T1 (de) | Pharmazeutische zusammensetzung | |
| Rizwan et al. | pH sensitive hydrogels in drug delivery: Brief history, properties, swelling, and release mechanism, material selection and applications | |
| WO2007040469A3 (en) | Chloroquine coupled compositions and methods for their synthesis | |
| MXPA05003591A (es) | Materiales basados en ciclodextrina, composiciones y usos relacionados a los mismos. | |
| ATE424848T1 (de) | Pharmazeutische zusammensetzungen für die kontrollierte freigabe von biologischen wirkstoffen | |
| WO2009135190A3 (en) | Therapeutic calcium phosphate particles and methods of making and using same | |
| MX2009005727A (es) | Nanoparticulas de entidad anfifilica. | |
| WO2006060723A3 (en) | Methods for producing block copolymer/amphiphilic particles | |
| ATE522200T1 (de) | Aripiprazole injektionsuspension | |
| EA201171279A1 (ru) | Производство инкапсулированных наночастиц с высокой объемной долей | |
| EA201170039A1 (ru) | Полимерные частицы, нагруженные лекарственным средством, и способы их получения и применения | |
| DE602006014990D1 (de) | Intranasale verabreichung von schnell wirkendem insulin | |
| MY149156A (en) | Solid dosage form comprising proton pump inhibitor and suspension made thereof | |
| GEP20115200B (en) | Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same | |
| Pahwa et al. | Chitosan-based gastroretentive floating drug delivery technology: an updated review | |
| DE60312333D1 (de) | Einen lipophilen wirkstoff enthaltende feste pharmazeutische zusammensetzung sowie deren herstellung | |
| ATE470443T1 (de) | Indol-1-yl-essigsäurederivate | |
| ATE454405T1 (de) | Hydrogele von polysaccharidmischungen für das gewebe-engineering und als wirkstoffträger | |
| NO20073529L (no) | Preparater og fremgangsmater for behandling av tilstander i negleenheten | |
| EA200900572A1 (ru) | Мицеллярные наночастицы с химическими субстанциями | |
| ATE459345T1 (de) | Wirkstoffpartikelhaltiges transdermales therapeutisches system mit erhöhtem wirkstofffluss | |
| WO2008085556A3 (en) | Surfactant-free nanoparticles for drug delivery | |
| WO2006137856A3 (en) | Method for the production of nanoparticles and microparticles by ternary agent concentration and temperature alteration induced immiscibility | |
| TW200635616A (en) | Organic compounds | |
| ATE486583T1 (de) | Pharmazeutische zusammensetzung enthaltend anastrozol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |